Zobrazeno 1 - 10
of 540
pro vyhledávání: '"Jean J.M.C.H de la Rosette"'
Publikováno v:
European urology, 63(2), e25-e26. Elsevier
CROES PCNL Study Group 2013, ' Reply to Chandra Shekhar Biyani, Andy Myatt, Victor Palit, Neil Burgess and Adrian D. Joyce's letter to the editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of complications and validation of the clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-55. ', European Urology (Italian Edition), vol. 63, no. 2, pp. e25-e26 . https://doi.org/10.1016/j.eururo.2012.11.001
CROES PCNL Study Group 2013, ' Reply to Chandra Shekhar Biyani, Andy Myatt, Victor Palit, Neil Burgess and Adrian D. Joyce's letter to the editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of complications and validation of the clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-55. ', European Urology (Italian Edition), vol. 63, no. 2, pp. e25-e26 . https://doi.org/10.1016/j.eururo.2012.11.001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6baaf1cb771f4955a217cea3036679c7
https://pure.amc.nl/en/publications/reply-to-chandra-shekhar-biyani-andy-myatt-victor-palit-neil-burgess-and-adrian-d-joyces-letter-to-the-editor-re-jean-jmch-de-la-rosette-dedan-opondo-francisco-pj-daels-et-al-on-behalf-of-the-croes-pcnl-study-group-categorisation-of-complications-and-validation-of-the-clavien-score-for-percutaneous-nephrolithotomy-eur-urol-20126224655(59510699-5edd-43b0-acb9-88bcf54d9cda).html
https://pure.amc.nl/en/publications/reply-to-chandra-shekhar-biyani-andy-myatt-victor-palit-neil-burgess-and-adrian-d-joyces-letter-to-the-editor-re-jean-jmch-de-la-rosette-dedan-opondo-francisco-pj-daels-et-al-on-behalf-of-the-croes-pcnl-study-group-categorisation-of-complications-and-validation-of-the-clavien-score-for-percutaneous-nephrolithotomy-eur-urol-20126224655(59510699-5edd-43b0-acb9-88bcf54d9cda).html
Autor:
de la Rosette JJ, Opondo D
Publikováno v:
European urology [Eur Urol] 2013 Feb; Vol. 63 (2), pp. e25-6. Date of Electronic Publication: 2012 Nov 10.
Publikováno v:
European urology [Eur Urol] 2013 Feb; Vol. 63 (2), pp. e23-4. Date of Electronic Publication: 2012 Nov 02.
Publikováno v:
Burgess, N, CROES PCNL Study Group & Osther, P J S 2013, ' Re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of complications and validation of the clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-55 ', European Urology (Italian Edition), vol. 63, no. 2, pp. e23-e24 . https://doi.org/10.1016/j.eururo.2012.10.044
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55656f1900ec1b5ec133d918cfd37fa8
https://doi.org/10.1016/j.eururo.2012.10.044
https://doi.org/10.1016/j.eururo.2012.10.044
Autor:
Arun Chawla, Sunil Pillai Bhaskara, Ravi Taori, Jean J.M.C.H de la Rosette, Pilar Laguna, Akhilesh Pandey, Sitaram Mummalaneni, Padmaraj Hegde, Shwetapriya Rao, Prakashini K
Publikováno v:
Therapeutic Advances in Urology, Vol 14 (2022)
Introduction: Emphysematous pyelonephritis (EPN), an acute necrotizing infection of the kidney and surrounding tissues, is associated with considerable mortality. We evaluated how existing critical care scoring systems could predict the need for inte
Externí odkaz:
https://doaj.org/article/c8454823897d45918a4f3ccfede15b01
Autor:
Robert J. Motzer
Publikováno v:
New England Journal of Medicine. 360:1916-1917
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba21250a61e905d11510237704e1090
https://doi.org/10.1056/nejmbkrev0807027
https://doi.org/10.1056/nejmbkrev0807027
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than
Externí odkaz:
https://doaj.org/article/65c6f4a598e64122ab11ca4b987c8e1c
Autor:
Matthijs J. Scheltema, Arnoud W. Postema, Daniel M. de Bruin, Mara Buijs, Marc R. Engelbrecht, M. Pilar Laguna, Hessel Wijkstra, Theo M. de Reijke, Jean J.M.C.H. de la Rosette
Publikováno v:
Diagnostic and Interventional Radiology, Vol 23, Iss 5, Pp 365-370 (2017)
Purpose:Imaging plays a crucial role in ablative therapies for prostate cancer (PCa). Irreversible electroporation (IRE) is a new treatment modality used for focal treatment of PCa. We aimed to demonstrate what imaging modalities can be used by descr
Externí odkaz:
https://doaj.org/article/0ee7b89e96ec42d38008bef83f1cfe88
Autor:
Estefanía Linares-Espinós, Thomas R. W. Herrmann, Arnulf Stenzl, Carlos R Trelles Guzmán, Stavros Gravas, Alexey Martov, Thomas Knoll, Charalampos Mamoulakis, Rodolfo Hurle, P. Laguna, Jean J.M.C.H. de la Rosette, Gabriel Favre, Mustafa Yucel Boz, Manuel Castanheira de Oliveira
Publikováno v:
World Journal of Urology. 40:727-738
Purpose White light (WL) is the traditional imaging modality for transurethral resection of bladder tumour (TURBT). IMAGE1S is a likely addition. We compare 18-mo recurrence rates following TURBT using IMAGE1S versus WL guidance. Methods Twelve inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f10192b7fb4a80bc35e62323944e91
https://doi.org/10.1007/s00345-021-03866-4
https://doi.org/10.1007/s00345-021-03866-4
Autor:
Varaha S Tammisetti, Peter-Paul Willemse, Daniel Rukstalis, Veeru Kasivisvanathan, Xavier Cathelineau, Yoh Matsuoka, Willemien Van Den Bos, Giorgio Gandaglia, Soroush Rais-Bahrami, Takumi Shiraishi, Massimo Valerio, Ardeshir R. Rastinehad, Cary N. Robertson, Herbert Lepor, Rajan T Gupta, Juan Gomez Rivas, Toshitaka Shin, Ariel Schulman, Yann Barbe, A.L. Abreu, Marco Moschini, Arvin K. George, Marco Oderda, Armando Stabile, Amir H. Lebastchi, Nathan Lawrentschuk, Daniel Margolis, Georg Salomon, M.P. Laguna, Wei Phin Tan, Jean J.M.C.H. de la Rosette, Derek Lomas, Christian P Pavlovich, Hazem Orabi, Bernard Malavaud, Abhinav Sidana, Osamu Ukimura, Sherif Mehralivand, Justin Gregg, Fernando Bianco, Thomas J. Polascik, Jochen Walz, Giancarlo Marra, Petr Macek, Rafael Sanchez-Salas, Sunao Shoji, Mesut Remzi, A. Villers
Publikováno v:
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica S.p.A.
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Minerva Urology and Nephrology, 74(5), 581-589. Edizioni Minerva Medica
Background Focal Therapy (FT) for Prostate Cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in selecting, treating and following u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5674c39c2c1157340f1c0353262367
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html
https://pure.amc.nl/en/publications/molecular-biomarkers-in-the-context-of-focal-therapy-for-prostate-cancer(df7bf651-87c7-44e5-bf47-9d2e9141567d).html